載入...
Transcriptomic and Epigenomic Profiling of Histone Deacetylase Inhibitor Treatment Reveals Distinct Gene Regulation Profiles Leading to Impaired Neutrophil Development
The clinical use of histone deacetylase inhibitors (HDACi) for the treatment of bone marrow failure and hematopoietic malignancies has increased dramatically over the last decades. Nonetheless, their effects on normal myelopoiesis remain poorly evaluated. Here, we treated cord blood derived CD34+ pr...
Na minha lista:
發表在: | Hemasphere |
---|---|
Main Authors: | , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Wolters Kluwer Health
2019
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745919/ https://ncbi.nlm.nih.gov/pubmed/31723844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000270 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|